In this case, CXCR3+ tumor-specific T cells accumulate into tumors through interaction with CXCR3 ligands (CXCL9, CXCL10, and CXCL11) (Franciszkiewicz et al., 2012). This evidence concerns the gene CXCL9 and neoplasm.